EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Clinical trial NCT03057977 · COMPLETED
Trial details
- NCT number
- NCT03057977
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-06
- Primary completion
- 2020-05-01
- Enrollment
- 3730
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.